Healthcare stocks were mostly down this afternoon, with the NYSE Health Care Index dropping 1%, while the SPDR Health Care Select Sector ETF (XLV) fell 0.8%.
The Nasdaq Biotechnology Index also fell 0.8%.
In company news, Procept BioRobotics (PRCT) fell 0.7% after the surgical robotics company announced Monday that it had negotiated a five-year, $52 million term loan that it used to draw down its existing $50 million credit facility. The new loan with CIBC Innovation Banking includes a three-year interest-only feature that can be extended to 48 months, the company said.
Tilray Brands (TLRY) fell 2.4% this afternoon, returning an early morning lead of more than 3% that trailed Cantor Fitzgerald who raised his price target $0.35 to $4.50 per share and reiterated its neutral rating for the action.
Immunic (IMUX) rose more than 44% after the immunotherapy company announced a $60 million private investment in an equity financing deal with a group of new and existing accredited investors consisting of nearly 13 .8 million common shares or pre-funded warrants priced at $4.35 a piece.